Cite
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort.
MLA
Faiz, Sarah, et al. “Effectiveness and Safety of Dupilumab for the Treatment of Atopic Dermatitis in a Real-Life French Multicenter Adult Cohort.” Journal of the American Academy of Dermatology, vol. 81, no. 1, July 2019, pp. 143–51. EBSCOhost, https://doi.org/10.1016/j.jaad.2019.02.053.
APA
Faiz, S., Giovannelli, J., Podevin, C., Jachiet, M., Bouaziz, J.-D., Reguiai, Z., Nosbaum, A., Lasek, A., Ferrier le Bouedec, M.-C., Du Thanh, A., Raison-Peyron, N., Tetart, F., Duval-Modeste, A.-B., Misery, L., Aubin, F., Dompmartin, A., Morice, C., Droitcourt, C., Soria, A., & Arnault, J.-P. (2019). Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort. Journal of the American Academy of Dermatology, 81(1), 143–151. https://doi.org/10.1016/j.jaad.2019.02.053
Chicago
Faiz, Sarah, Jonathan Giovannelli, Céline Podevin, Marie Jachiet, Jean-David Bouaziz, Ziad Reguiai, Audrey Nosbaum, et al. 2019. “Effectiveness and Safety of Dupilumab for the Treatment of Atopic Dermatitis in a Real-Life French Multicenter Adult Cohort.” Journal of the American Academy of Dermatology 81 (1): 143–51. doi:10.1016/j.jaad.2019.02.053.